Patents by Inventor Stephen GOODALL

Stephen GOODALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPROVED VIRUCIDAL FORMULATIONS
    Publication number: 20230233600
    Abstract: The present invention is directed to PVP-I formulations having enhanced virucidal activity. The formulations are intended for topical administration for treatment and/or decreased risk of microbial infections in subjects. The formulations include PVP-I and other ingredients selected to enhance the virucidal activity of the formulation over PVP-I alone.
    Type: Application
    Filed: June 10, 2021
    Publication date: July 27, 2023
    Applicant: FIREBRICK PHARMA LIMITED
    Inventors: Peter MOLLOY, Simon TUCKER, Stephen GOODALL
  • PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES
    Publication number: 20220168338
    Abstract: This invention is directed to methods for prevention of infections by highly pathogenic viruses by applying to the nasal mucous membranes topical preparations comprising the broad-spectrum antimicrobial agent povidone-iodine.
    Type: Application
    Filed: December 7, 2021
    Publication date: June 2, 2022
    Applicant: FIREBRICK PHARMA LIMITED
    Inventors: Peter MOLLOY, Stephen GOODALL
  • PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES
    Publication number: 20220088067
    Abstract: This invention is directed to methods for prevention of infections by highly pathogenic viruses by applying to the nasal mucous membranes topical preparations comprising the broad-spectrum antimicrobial agent povidone-iodine.
    Type: Application
    Filed: December 7, 2021
    Publication date: March 24, 2022
    Applicant: FIREBRICK PHARMA LIMITED
    Inventors: Peter MOLLOY, Stephen GOODALL
  • PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES
    Publication number: 20200384016
    Abstract: This invention is directed to methods for prevention of infections by highly pathogenic viruses by applying to the nasal mucous membranes topical preparations comprising the broad-spectrum antimicrobial agent povidone-iodine.
    Type: Application
    Filed: July 10, 2020
    Publication date: December 10, 2020
    Applicant: FIREBRICK PHARMA PTY LTD
    Inventors: Peter MOLLOY, Stephen GOODALL
  • TREATMENT AND PREVENTION OF THE COMMON COLD USING POVIDONE-IODINE
    Publication number: 20200316109
    Abstract: The present invention provides a method of treating and preventing the common cold and associated secondary illnesses in a human subject, when the common cold is caused by viruses. The method comprises applying to the nasal passages of the human subject at ambient temperature, an effective amount of a pharmaceutical preparation comprising povidone-iodine (PVP-I) at a concentration of greater than 0.10% w/v and less than 2.5% in which at least 50% of the PVP-I is not associated with liposomes or other particulate carriers.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Applicant: FIREBRICK PHARMA PTY LTD
    Inventors: Stephen GOODALL, Peter MOLLOY
  • TREATMENT AND PREVENTION OF THE COMMON COLD USING POVIDONE-IODINE
    Publication number: 20170165296
    Abstract: The present invention provides a method of treating and preventing the common cold and associated secondary illnesses in a human subject, when the common cold is caused by viruses. The method comprises applying to the nasal passages of the human subject at ambient temperature, an effective amount of a pharmaceutical preparation comprising povidone-iodine (PVP-I) at a concentration of greater than 0.10% w/v and less than 2.5% in which at least 50% of the PVP-I is not associated with liposomes or other particulate carriers.
    Type: Application
    Filed: July 6, 2015
    Publication date: June 15, 2017
    Applicant: FIREBRICK PHARMA PTY LTD
    Inventors: Stephen GOODALL, Peter MOLLOY